Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. OncoBEAM RAS CRC for metastatic colorectal cancer. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2015 Authors' objectives OncoBeam RAS CRC, developed by Sysmex Inostics, is a blood-based polymerase chain reaction (PCR) test for the detection of KRAS and NRAS gene mutations in patients with metastatic colorectal cancer (mCRC). The test is intended to be used to help determine whether a patient would be suitable for treatment with anti-epidermal growth factor receptor (EGFR) therapy. Indexing Status Subject indexing assigned by CRD MeSH Colorectal Neoplasms; Humans; ras Proteins Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Research&Intelligence Centre, University of Birmingham, Institute of Applied Health Research, Public Health building, Edgbaston, Birmingham B15 2TT
Tel: 0121 414 9077 Email: nihrhsc@contacts.bham.ac.uk AccessionNumber 32016000471 Date abstract record published 08/03/2016 |